SGLT2 Inhibitors and the Risk of Hospitalization for Fournier's Gangrene: A Nested Case-Control Study.
Tongtong WangShrita M PatelAnne HickmanXinyue LiuPhilip LStJ JonesIra GantzCarol E KoroPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
The study did not find that treatment with SGLT2i, as compared with treatment with two or more non-SGLT2i AHAs or insulin alone, was statistically significantly associated with an increased risk of hospitalization for FG. Additional studies are needed to corroborate the findings.